miRNA-24-3p promotes cell proliferation and regulates chemosensitivity in head and neck squamous cell carcinoma by targeting CHD5

Is miR-34a a Well-equipped Swordsman to Conquer Temple of Molecular Oncology?

(2016) Ammad Ahmad Farooqi et al.   Chemical Biology & Drug Design

Exome Sequencing of Normal and Isogenic Transformed Human Colonic Epithelial Cells (HCECs) Reveals Novel Genes Potentially Involved in the Early Stages of Colorectal Tumorigenesis

(2015) Lu Zhang et al.   BMC GENOMICS

Anticancer drugs for the modulation of endoplasmic reticulum stress and oxidative stress

(2015) Ammad Ahmad Farooqi et al.   TUMOR BIOLOGY

Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma

(2015) Shu-biao Ye et al.   Oncotarget

Mutation and Methylation Analysis of the Chromodomain-Helicase-DNA Binding 5 Gene in Ovarian Cancer

(2015) Kylie L. Gorringe et al.   NEOPLASIA

miR-421, miR-155 and miR-650: Emerging Trends of Regulation of Cancer and Apoptosis

(2014) Ammad Ahmad Farooqi et al.   Asian Pacific Journal of Cancer Prevention

Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior

(2014) Yang Gao et al.   MEDICAL ONCOLOGY

Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma

(2014) Fan-Long Meng et al.   MEDICAL ONCOLOGY

Epigenetic silencing ofCHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages

(2013) Mehrnaz Fatemi et al.   CANCER

CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer

(2013) L. Burkhardt et al.   CANCER RESEARCH

miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells

(2013) Sundas Fayyaz et al.   IMMUNOGENETICS

Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma

(2013) Liang Wang et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Identification of novel driver tumor suppressors through functional interrogation of putative passenger mutations in colorectal cancer

(2012) Lu Zhang et al.   INTERNATIONAL JOURNAL OF CANCER

CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer

(2011) Raymond R.Y. Wong et al.   GYNECOLOGIC AND OBSTETRIC INVESTIGATION

Genetic and expressional alterations of CHD genes in gastric and colorectal cancers

(2011) Min Sung Kim et al.   HISTOPATHOLOGY

CHD5, a tumor suppressor that is epigenetically silenced in lung cancer

(2011) Rui Zhao et al.   LUNG CANCER

Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness

(2011) S Huang et al.   ONCOGENE

The involvement of CHD5 hypermethylation in laryngeal squamous cell carcinoma

(2011) Jin Wang et al.   ORAL ONCOLOGY

The microRNA pathway and cancer

(2010) Pieter Bas Kwak et al.   CANCER SCIENCE

A Rat Monoclonal Antibody Against the Chromatin Remodeling Factor CHD5

(2010) Saori Yoshimura et al.   HYBRIDOMA

Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases

(2010) Ravindresh Chhabra et al.   Molecular Cancer

Role of chromodomain helicase DNA-binding protein 2 in DNA damage response signaling and tumorigenesis

(2009) P Nagarajan et al.   ONCOGENE

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

(2009) Jean-Pierre Pignon et al.   RADIOTHERAPY AND ONCOLOGY

MicroRNAs in Cancer

(2008) Yong Sun Lee et al.   Annual Review of Pathology-Mechanisms of Disease

The Quest for the 1p36 Tumor Suppressor

(2008) A. Bagchi et al.   CANCER RESEARCH

Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

(2008) Mitchell Machtay et al.   JOURNAL OF CLINICAL ONCOLOGY